0 NASDAQ Companies - July 17, 2019NuCana Announces First Patients Dosed in Phase I Study of NUC-7738Read More
0 NASDAQ Companies - July 17, 2019AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer™, an Investigational Treatment for Alzheimer’s DiseaseRead More
0 NASDAQ Companies - July 17, 2019Pluristem and U.S. Department of Defense to Announce Data from Studies Testing PLX-R18 as a Prophylactic Treatment for Acute Radiation Syndrome at RITNRead More
0 TSX Venture News - July 17, 2019Initial Results of Saddle North Phase One Drilling Demonstrate Continuity of High-Grade Cu-Au Porphyry from Surface: 500 Metres of 0.91 g/t Au, 0.55 % Cu, 1.34 g/t Ag (1.23 % CuEq; 1.67 g/t AuEq)Read More
0 NASDAQ Companies - July 17, 2019RADA Schedules Second Quarter 2019 Results Release & Conference Call on Wednesday, August 21, 2019Read More
0 NYSE Companies - July 17, 2019Zomedica Announces Initiation of a Digital Data Platform Enhancing its Diagnostic PipelineRead More
0 NASDAQ Companies - July 17, 2019Vislink Technologies Closes $12 Million Offering, Pays off Convertible Debt in Full and Ahead of ScheduleRead More
